Published April 28, 2026
| Version v1
Preprint
Open
Ivacaftor-Lumacaftor Combination for CBAVD-Associated CFTR Dysfunction
Description
Lumacaftor acts as a CFTR corrector facilitating proper protein folding and trafficking to cell surface, while ivacaftor functions as a potentiator increasing chloride channel gating probability. This dual mechanism addresses both the processing defects and reduced function of mutant CFTR proteins commonly associated with CBAVD, potentially restoring ductal fluid secretion necessary for vas deferens patency.
Notes
Files
hypothesis.json
Files
(403 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:bd260be6dd50040c258b823736fcfa61
|
403 Bytes | Preview Download |